Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

Latest News

6 die in Indonesia riots; Widodo says he won't allow unrest

May 25, 2019

JAKARTA, Indonesia — Indonesian President Joko Widodo said authorities have the volatile situation in the country's capital under control after six people died Wednesday in riots by supporters of his losing rival in last month's presidential election. The clashes began Tuesday night when supporters of former Gen. Prabowo Subianto tried to force their way into the downtown offices of the election supervisory agency and have continued unabated since then. More than two dozen vehicles were burned as rioters took over neighborhoods in central Jakarta, throwing rocks and Molotov cocktails at police who responded with tear gas, water cannons and rubber...

Boeing 737 Max 8 woes crimp Asian airlines' growth plans

May 25, 2019

SINGAPORE — Asian airlines are cutting routes, revamping their schedules and leasing extra aircraft to fill gaps left by the grounding of Boeing 737 Max 8s after deadly crashes in Indonesia and Ethiopia killed 346 people. So far, regional carriers have managed to avoid major disruptions, but analysts expect that idling the Max 8s, a fuel-efficient update of Boeing's popular 737, will crimp growth plans in the near future. As investigations into the crashes continue, Boeing anticipates a $1 billion increase in costs related to the 737 Max, including fixing software implicated in the disasters, adding pilot training and compensating...

Brunei death penalty moratorium applied to new Shariah laws

May 25, 2019

KUALA LUMPUR, Malaysia — Brunei's sultan has said a moratorium on capital punishment is in effect for new Shariah criminal laws including stoning people for gay sex and adultery that sparked an international outcry. The United Nations has called the laws implemented April 3 "draconian" while the U.S. and several other countries have urged Brunei to halt its plans. Celebrities including George Clooney, Elton John and Ellen DeGeneres have rallied for a boycott of nine hotels in the U.S. and Europe linked to Brunei. Even before 2014, homosexuality was already punishable in Brunei by a jail term of up to...

Thai king celebrates coronation with spectacular parade

May 25, 2019

BANGKOK — Thailand's newly crowned King Maha Vajiralongkorn made a spectacular public appearance in front of his countrymen Sunday, carried atop a golden palanquin by soldiers in ancient fighting uniforms in a procession through Bangkok's historic quarter. Hundreds of other soldiers marched in front, behind and alongside the palanquin in scorching heat as the procession set off from Bangkok's Grand Palace just after 5 p.m. with a marching band setting the pace. Also taking part in the slow parade were the prime minister and other senior officials in the military government as well as the king's wife, Queen Suthida, and...

Thai king is officially crowned, boosting his regal power

May 25, 2019

BANGKOK — Thailand's King Maha Vajiralongkorn was officially crowned Saturday in an elaborate centuries-old royal tradition that last happened seven decades ago. The coronation represents a renewal of the monarchy's power after the October 2016 death of Vajiralongkorn's revered father, King Bhumibol Adulyadej. It also comes amid more than a decade of political strife, including a 2014 military coup and a contentious election less than two months ago. The 66-year-old Vajiralongkorn has served as king for more than two years since he assumed the throne. On Saturday, he took the crown from the chief Brahmin, a Hindu priest who has...

Sign up now!